NanoViricides(NNVC) - 2025 Q3 - Quarterly Report

QUARTERLY REPORT UNDER SECTION 1320 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended March 31, 2025 Commission File Number: 001-36081 NANOVIRICIDES, INC. (Exact name of Company as specified in its charter) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Address of principal executive offices and zip code) (203) 937-6137 (Company's telephone number, including area code) Indicate by check mark whether the Company (1) has filed ...